Epista Life Science further strengthens leadership team

Flemming Kjøller picks up the baton as Chief Growth Officer (CGO) with focus on further accelerating the growth and drive international expansion

Epista Life Science, a Hørsholm-based consultancy dedicated to Life Science, hires Flemming Kjøller to further accelerate the company’s growth and internationalization. In 2022, Epista Life Sciences was acquired by FSN Capital Partners, a leading Northern European private equity firm. This sparked a new phase in Epista Life Science’s journey with the aim of establishing an international, full-service platform for Life Science consulting.

Epista CEO Klavs Esbjerg comments, “Today, Epista Life Science is a strong, well-established Northern European end-to-end Life Sciences consultancy business, but we still have so much potential to grow and advance our mission of continuously improving compliance and business for our clients and the Life Science industry. That is why it makes sense for us to take another significant step forward and focus on expanding our organization and customer base both locally and internationally. I look forward to working closely with Flemming and the rest of Epista to fulfill the ambitious growth strategy that has been outlined and aligned with FSN Capital Partners.”

About Flemming Kjøller

Flemming Kjøller joins Epista Life Science with more than 25 years of experience as a leader in the IT industry and 12 years specifically focused on international Life Science. Most recently as Corporate Vice President of Life Sciences for 10+ years, Kjøller utilized his knowledge and experience to lead strong international growth at NNIT A/S by spearheading their international commercial organization. During this time, he has been building and driving partnerships globally with Life Science companies while working to enable business transformation through technological changes and advancements.

Kjøller accomplished these achievements in a variety of senior leadership positions focused on strategic business growth, commercial strategy execution, and organizational development. Before his time at NNIT, Flemming spent 6 years as a part of Fujitsu’s Danish and Scandinavian leadership team and 10 years at IBM Global Services in international sales, M&A, solution leadership, and project management positions.

“Epista Life Science has a strong reputation in the Life Science industry, and I’m very impressed with Epista’s vibe, culture, way of working, and overall impressive organizational development. I look forward to building further on this great foundation together with Epista Life Science’s leadership team and its many committed employees”, says Flemming Kjøller.

About Epista Life Science (“Epista”)

Epista, founded in 2009, is an IT services and consultancy firm assisting Life Science companies worldwide. They are headquartered in Denmark and have subsidiaries in Sweden and Germany. The company works at the intersection of business and compliance to anticipate the impacts that changing technology and regulatory requirements will have on the industry. They implement technologies and pioneer methodologies to help their clients adapt while also increasing their performance. In this way, they help the industry drive the innovations that improve health care around the world.

For more information please contact Epista Life Science:

Bobby William Gray, Chief Commercial Officer

Klavs Esbjerg, CEO, Epista Life Science

Talk to an expert

Klavs Esbjerg
CEO & Founder

Explore other articles

Get in touch

We enjoy sharing our knowledge. Get in touch to find out how Epista can add value to your Life Science company.